{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:20:15Z","timestamp":1790277615643,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clim.2022.108960","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T02:33:32Z","timestamp":1645670012000},"page":"108960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"236","author":[{"given":"Wenli","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10100","key":"10.1016\/j.clim.2022.108960_bb0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1164\/ajrccm\/147.3.697","article-title":"Airway mucosal inflammation even in patients with newly diagnosed asthma","volume":"147","author":"Laitinen","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"1S","key":"10.1016\/j.clim.2022.108960_bb0015","first-page":"S1","article-title":"Global initiative for asthma (GINA) strategy 2021 - executive summary and rationale for key changes","volume":"10","author":"Reddel","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2022.108960_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/JAA.S14420","article-title":"Current recommendations for the treatment of mild asthma","volume":"3","author":"Shahidi","year":"2010","journal-title":"J. Asthma Allergy"},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0025","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jaci.2008.02.029","article-title":"The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma","volume":"121","author":"Busse","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0895-4356(92)90085-2","article-title":"Incorporating variations in the quality of individual randomized trials into meta-analysis","volume":"45","author":"Detsky","year":"1992","journal-title":"J. Clin. Epidemiol."},{"issue":"3 Pt 1","key":"10.1016\/j.clim.2022.108960_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3476(98)70023-X","article-title":"Growth in asthmatic children treated with fluticasone propionate. Fluticasone propionate asthma study group","volume":"132","author":"Allen","year":"1998","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2500\/aap.2016.37.3983","article-title":"Safety and efficacy of beclomethasone dipropionate delivered by breath-actuated or metered-dose inhaler for persistent asthma","volume":"37","author":"Amar","year":"2016","journal-title":"Allergy Asthma Proc."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ppul.23563","article-title":"Mometasone furoate (MF) improves lung function in pediatric asthma: a double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler","volume":"52","author":"Amar","year":"2017","journal-title":"Pediatr. Pulmonol."},{"issue":"21","key":"10.1016\/j.clim.2022.108960_bb0055","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0060","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S1081-1206(10)61342-7","article-title":"Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study","volume":"96","author":"Becker","year":"2006","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1081-1206(10)63547-8","article-title":"Once-daily evening administration of mometasone furoate in asthma treatment initiation","volume":"96","author":"Bensch","year":"2006","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.anai.2011.07.017","article-title":"Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: a randomized, double-blind, placebo-controlled trial","volume":"107","author":"Bensch","year":"2011","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpeds.2004.08.060","article-title":"Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze","volume":"146","author":"Berger","year":"2005","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1081-1206(10)61099-X","article-title":"Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma","volume":"97","author":"Berger","year":"2006","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0085","first-page":"49","article-title":"Efficacy and safety of budesonide\/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma","volume":"31","author":"Berger","year":"2010","journal-title":"Allergy Asthma Proc."},{"issue":"9","key":"10.1016\/j.clim.2022.108960_bb0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0954-6111(99)90099-9","article-title":"Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler","volume":"93","author":"Bernstein","year":"1999","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0095","first-page":"559","article-title":"Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: a randomized, controlled, dose-ranging study","volume":"54","author":"Bernstein","year":"2017","journal-title":"J. Asthma Off. J. Assoc. Care Asthma"},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaip.2014.02.010","article-title":"Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial","volume":"2","author":"Bleecker","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0091-6749(96)70221-X","article-title":"Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study","volume":"98","author":"de Blic","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00044011-200828020-00004","article-title":"Combined salmeterol\/fluticasone propionate versus fluticasone propionate alone in mild asthma\u202f: a placebo-controlled comparison","volume":"28","author":"Boonsawat","year":"2008","journal-title":"Clin. Drug Invest."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1067\/mai.2001.114657","article-title":"Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial","volume":"107","author":"Busse","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2022.108960_bb0120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/all.12480","article-title":"Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial","volume":"69","author":"Busse","year":"2014","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.clim.2022.108960_bb0125","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.rmed.2005.04.008","article-title":"The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms","volume":"99","author":"Carlsen","year":"2005","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1398-9995.2004.00750.x","article-title":"Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma","volume":"60","author":"Chapman","year":"2005","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00044011-200828030-00004","article-title":"Salmeterol\/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids","volume":"28","author":"Chuchalin","year":"2008","journal-title":"Clin. Drug Invest."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.clinthera.2007.05.011","article-title":"Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma","volume":"29","author":"Corren","year":"2007","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rmed.2012.10.025","article-title":"Efficacy and safety of fluticasone\/formoterol combination therapy in patients with moderate-to-severe asthma","volume":"107","author":"Corren","year":"2013","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.clim.2022.108960_bb0150","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1185\/030079905X56402","article-title":"Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids","volume":"21","author":"D\u2019Urzo","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40264-020-01041-z","article-title":"Safety of as-needed budesonide-formoterol in mild asthma: data from the two phase III SYGMA studies","volume":"44","author":"FitzGerald","year":"2021","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1081-1206(10)62608-7","article-title":"Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma","volume":"82","author":"Galant","year":"1999","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jpeds.2005.10.028","article-title":"Once-daily ciclesonide in children: efficacy and safety in asthma","volume":"148","author":"Gelfand","year":"2006","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0954-6111(94)90059-0","article-title":"Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma","volume":"88","author":"Jones","year":"1994","journal-title":"Respir. Med."},{"issue":"12","key":"10.1016\/j.clim.2022.108960_bb0175","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1345\/aph.1G410","article-title":"Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma","volume":"39","author":"Karpel","year":"2005","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0180","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.rmed.2006.06.005","article-title":"Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma","volume":"101","author":"Karpel","year":"2007","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0149-2918(98)80053-2","article-title":"Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Propionate Study Group","volume":"20","author":"Katz","year":"1998","journal-title":"Clin. Ther."},{"issue":"6 Pt 1","key":"10.1016\/j.clim.2022.108960_bb0190","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1067\/mai.2000.105711","article-title":"Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial","volume":"105","author":"Kavuru","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1081-1206(10)62646-4","article-title":"Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children","volume":"83","author":"Kemp","year":"1999","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4065\/79.4.458","article-title":"Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial","volume":"79","author":"Kemp","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.rmed.2007.12.002","article-title":"Efficacy and safety of fluticasone propionate\/salmeterol 250\/50 mcg Diskus administered once daily","volume":"102","author":"Kerwin","year":"2008","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0210","first-page":"89","article-title":"Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids","volume":"54","author":"Kerwin","year":"2017","journal-title":"J. Asthma Off. J. Assoc. Care Asthma"},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0215","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.pupt.2008.06.004","article-title":"Fluticasone or montelukast for preschool children with asthma-like symptoms: randomized controlled trial","volume":"21","author":"Kooi","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1081-1206(10)62556-2","article-title":"Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma","volume":"85","author":"LaForce","year":"2000","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"10","key":"10.1016\/j.clim.2022.108960_bb0225","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.rmed.2005.05.024","article-title":"Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma","volume":"99","author":"Langdon","year":"2005","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0230","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2500\/aap.2016.37.3968","article-title":"Efficacy and safety evaluation of once-daily fluticasone furoate\/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid\/long-acting beta2-agonist","volume":"37","author":"Lin","year":"2016","journal-title":"Allergy Asthma Proc."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1081-1206(10)61117-9","article-title":"Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma","volume":"94","author":"Lipworth","year":"2005","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rmed.2013.11.009","article-title":"Efficacy and safety of fluticasone furoate 100 \u03bcg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial","volume":"108","author":"L\u00f6tvall","year":"2014","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1081-1206(10)61040-X","article-title":"Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids","volume":"96","author":"Lumry","year":"2006","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"9766","key":"10.1016\/j.clim.2022.108960_bb0250","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0255","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaip.2013.07.011","article-title":"Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma","volume":"1","author":"Maspero","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2 Pt 1","key":"10.1016\/j.clim.2022.108960_bb0260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1164\/ajrccm.162.2.9909030","article-title":"Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma","volume":"162","author":"Mellon","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0265","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0025-6196(11)62212-X","article-title":"Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma","volume":"77","author":"Meltzer","year":"2002","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0270","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00020310","article-title":"Mometasone furoate\/formoterol reduces asthma deteriorations and improves lung function","volume":"39","author":"Meltzer","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0275","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1081-1206(10)61394-4","article-title":"Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists","volume":"93","author":"Murray","year":"2004","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0280","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1081-1206(10)63159-6","article-title":"A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma","volume":"82","author":"Nathan","year":"1999","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0285","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.118.2.296","article-title":"A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma","volume":"118","author":"Nathan","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clinthera.2006.01.008","article-title":"Efficacy and tolerability of fluticasone propionate\/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study","volume":"28","author":"Nathan","year":"2006","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2500\/aap.2010.31.3364","article-title":"Twenty-six-week efficacy and safety study of mometasone furoate\/formoterol 200\/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids","volume":"31","author":"Nathan","year":"2010","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.clim.2022.108960_bb0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2466-12-67","article-title":"Safety and efficacy of fluticasone\/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial","volume":"12","author":"Nathan","year":"2012","journal-title":"BMC Pulmonary Med."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1081-1206(10)62275-2","article-title":"Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma","volume":"84","author":"Nayak","year":"2000","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0310","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1378\/chest.122.6.1956","article-title":"Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study","volume":"122","author":"Nayak","year":"2002","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.clim.2022.108960_bb0315","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2165\/00003495-200666170-00006","article-title":"Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial","volume":"66","author":"Noonan","year":"2006","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-014-0088-z","article-title":"Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial","volume":"15","author":"O\u2019Byrne","year":"2014","journal-title":"Respir. Res."},{"issue":"246\u2013253","key":"10.1016\/j.clim.2022.108960_bb0325","article-title":"Randomized trial of once-daily fluticasone Furoate in children with inadequately controlled asthma","volume":"178","author":"Oliver","year":"2016","journal-title":"J. Pediatr."},{"issue":"20","key":"10.1016\/j.clim.2022.108960_bb0330","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0091-6749(98)70052-1","article-title":"Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma","volume":"102","author":"Peden","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2022.108960_bb0340","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.rmed.2010.06.012","article-title":"Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study","volume":"104","author":"Pedersen","year":"2010","journal-title":"Respir. Med."},{"issue":"20","key":"10.1016\/j.clim.2022.108960_bb0345","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMoa070013","article-title":"Randomized comparison of strategies for reducing treatment in mild persistent asthma","volume":"356","author":"Peters","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.clim.2022.108960_bb0350","first-page":"865","article-title":"Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma","volume":"42","author":"Pinnas","year":"2005","journal-title":"J. Asthma Off. J. Assoc. Care Asthma"},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0355","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.09-1735","article-title":"Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control","volume":"139","author":"Postma","year":"2011","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.clim.2022.108960_bb0360","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","article-title":"Leukotriene antagonists as first-line or add-on asthma-controller therapy","volume":"364","author":"Price","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0365","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jaci.2012.12.673","article-title":"Effect of montelukast for treatment of asthma in cigarette smokers","volume":"131","author":"Price","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0370","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2006.07.045","article-title":"Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study","volume":"149","author":"Qaqundah","year":"2006","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3132\/pcrj.2008.00014","article-title":"Does continuous use of inhaled corticosteroids improve outcomes in mild asthma? A double-blind randomised controlled trial","volume":"17","author":"Reddel","year":"2008","journal-title":"Primary Care Respiratory J.\u202f:J. General Practice Airways Group"},{"issue":"6 Pt 1","key":"10.1016\/j.clim.2022.108960_bb0380","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1542\/peds.111.6.e706","article-title":"Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma","volume":"111","author":"Roux","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0385","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pupt.2006.12.007","article-title":"Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial","volume":"21","author":"Schokker","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0390","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-3476(98)70394-4","article-title":"Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma","volume":"132","author":"Shapiro","year":"1998","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0395","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0091-6749(98)70019-3","article-title":"Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma","volume":"102","author":"Shapiro","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0400","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1081-1206(10)62291-0","article-title":"Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids","volume":"86","author":"Shapiro","year":"2001","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1081-1206(10)61285-9","article-title":"Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the inhaled steroid treatment as regular therapy in early asthma (START) study","volume":"94","author":"Sheffer","year":"2005","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0410","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2500\/aap.2017.38.4069","article-title":"Fluticasone propionate and fluticasone propionate\/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma","volume":"38","author":"Sher","year":"2017","journal-title":"Allergy Asthma Proc."},{"issue":"Suppl. 17","key":"10.1016\/j.clim.2022.108960_bb0415","first-page":"14","article-title":"Safety and tolerability of inhaled budesonide in children in the steroid treatment as regular therapy in early asthma (START) trial","volume":"17","author":"Silverman","year":"2006","journal-title":"Pediatric Allergy Immunol. Off. Publ. Eur. Soc. Pediatric Allergy Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0420","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2006-2206","article-title":"Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma","volume":"121","author":"Skoner","year":"2008","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.clim.2022.108960_bb0425","first-page":"848","article-title":"Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma","volume":"48","author":"Skoner","year":"2011","journal-title":"J. Asthma Off. J. Assoc. Care Asthma"},{"issue":"15","key":"10.1016\/j.clim.2022.108960_bb0430","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","author":"Szefler","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0435","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2007.08.063","article-title":"Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma","volume":"120","author":"Szefler","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0440","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/thorax.56.4.272","article-title":"Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years","volume":"56","author":"Tattersfield","year":"2001","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0445","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1542\/peds.92.1.64","article-title":"Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children","volume":"92","author":"Tinkelman","year":"1993","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0450","first-page":"265","article-title":"A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma","volume":"33","author":"Wasserman","year":"1996","journal-title":"J. Asthma Off. J. Assoc. Care Asthma"},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0455","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1081-1206(10)61343-9","article-title":"Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study","volume":"96","author":"Wasserman","year":"2006","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0460","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40264-013-0029-7","article-title":"Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis","volume":"36","author":"van Boven","year":"2013","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0465","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s15010-018-1229-y","article-title":"Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis","volume":"47","author":"Yang","year":"2019","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.clim.2022.108960_bb0470","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s40520-020-01688-9","article-title":"Inhaled corticosteroids and risk of influenza in patients with asthma: a meta-analysis of randomized controlled trials","volume":"33","author":"Chen","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.clim.2022.108960_bb0475","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fmb.09.108","article-title":"Innate immune evasion strategies of influenza viruses","volume":"5","author":"Hale","year":"2010","journal-title":"Future Microbiol."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0480","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1513\/pats.200402-018MS","article-title":"Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium","volume":"1","author":"Schleimer","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2022.108960_bb0485","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01844196","article-title":"An overview of glucocorticoid anti-inflammatory actions","volume":"45","author":"Schleimer","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.clim.2022.108960_bb0490","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3271","article-title":"Inhaled corticosteroids and respiratory infections in children with asthma: a meta-analysis","volume":"139","author":"Cazeiro","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clim.2022.108960_bb0495","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S2213-2600(14)70024-4","article-title":"Inhaled corticosteroids in children: effects on bone mineral density and growth","volume":"2","author":"Fuhlbrigge","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.clim.2022.108960_bb0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/ACI.0000000000000730","article-title":"Safety of anti-inflammatory drugs in children with asthma","volume":"21","author":"de Benedictis","year":"2021","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2022.108960_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008554","article-title":"Bone mineral density and fracture risk with long-term use of inhaled corticosteroids in patients with asthma: systematic review and meta-analysis","volume":"5","author":"Loke","year":"2015","journal-title":"BMJ Open"},{"issue":"26","key":"10.1016\/j.clim.2022.108960_bb0510","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","article-title":"Involutional osteoporosis","volume":"314","author":"Riggs","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2022.108960_bb0515","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pupt.2005.11.007","article-title":"The treatment of asthma in children: inhaled corticosteroids","volume":"20","author":"Ricciardolo","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.clim.2022.108960_bb0520","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2022.108960_bb0525","author":"NCT00163293 trial"},{"key":"10.1016\/j.clim.2022.108960_bb0530","author":"NCT00392288 trial"},{"key":"10.1016\/j.clim.2022.108960_bb0535","author":"NCT00569192 trial"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:50Z","timestamp":1761494690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":107,"alternative-id":["S1521661622000407"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.108960","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.108960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108960"}}